Donaldson Company Acquires Nivelles, Belgium-Based Univercells Technologies For €136M
Portfolio Pulse from Benzinga Newsdesk
Donaldson Company is acquiring Univercells Technologies from Gamma Biosciences and Univercells SA for €136M. Univercells Technologies, a producer of biomanufacturing solutions for cell and gene therapy research, will be a part of the Donaldson Life Sciences segment. The company generated approximately €10 million of revenue in 2022.
June 29, 2023 | 9:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Donaldson Company's acquisition of Univercells Technologies could potentially strengthen its Life Sciences segment. The deal is worth €136M.
The acquisition of Univercells Technologies, a company that generated €10 million in revenue in 2022, could potentially boost Donaldson Company's Life Sciences segment. This could lead to increased revenues and potentially a positive impact on the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100